Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438796
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-23
Brief Title:
Blinatumomab Maintenance After Allo-HSCT
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| High Risk Acute Lymphoblastic Leukemia |
Keywords: